These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients. Boisson-Vidal C; Haouam M; Lakhiari H; Huguet H; Dahri L; Sultan Y; Jozefonvicz J; Siali R Vox Sang; 2002 Oct; 83(3):214-21. PubMed ID: 12366762 [TBL] [Abstract][Full Text] [Related]
7. Catalytic antibodies to factor VIII in haemophilia A. Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S31-4. PubMed ID: 14567533 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG. Moreau A; Lacroix-Desmazes S; Stieltjes N; Saenko E; Kaveri SV; D'Oiron R; Sultan Y; Scandella D; Kazatchkine MD Blood; 2000 Jun; 95(11):3435-41. PubMed ID: 10828026 [TBL] [Abstract][Full Text] [Related]
9. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains. Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780 [TBL] [Abstract][Full Text] [Related]
10. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. Gilles JG; Saint-Remy JM J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study. Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717 [TBL] [Abstract][Full Text] [Related]
12. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates. Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150 [TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors. Grosbois SS; Brionne MF; de Longcamp AL; Gautier P; V Kaveri S; Borel-Derlon A; Repessé Y Haemophilia; 2013 Mar; 19(2):322-9. PubMed ID: 23216758 [TBL] [Abstract][Full Text] [Related]
18. Factor VIII inhibitor with catalytic activity towards factor VIII. Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Kazatchkine MD; Kaveri SV Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883 [TBL] [Abstract][Full Text] [Related]
19. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients. Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525 [TBL] [Abstract][Full Text] [Related]
20. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes. Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]